Enzyme costs play a major role in the choice of metabolic routes, both in evolution and bioengineering. Given desired fluxes, necessary enzyme levels can be estimated based on known rate laws and on a principle of minimal enzyme cost. With logarithmic metabolite levels as free variables, enzyme cost functions and constraints in optimality and sampling problems can be handled easily. The set of feasible metabolite profiles forms a polytope in log-concentration space, whose points represent all possible steady states of a kinetic model. We show that enzyme cost is a convex function on this polytope. This makes enzyme cost minimization -finding optimal enzyme profiles and corresponding metabolite profiles that realize a desired flux at a minimal cost -a convex optimization problem.
Introduction
The metabolic fluxes in cells are driven by enzymes, which come at a cost. Translating a given flux profile into the necessary enzyme profile, and computing the corresponding enzyme cost, is not a trivial task. In kinetic models, a reaction rates v = E · r(c) is a product of enzyme level E and an enzymespecific rate given by the rate law r(c). If metabolite levels were known, the enzyme demand could be directly computed; the specific enzyme demand E/v = 1/r(c) is simply obtained by inverting the rate law. However, since metabolite levels are not fixed, the fluxes in a network can be realized by many possible enzyme profiles, each with a corresponding metabolite profile. To select a plausible solution, we employ an optimality principle: we define an enzyme cost function (for instance, total enzyme mass) and choose among all possible enzyme profiles the one with the lowest cost. As a constraint, the corresponding metabolite profile must respect physiological ranges and energetic constraints implied by flux directions. The enzyme demand in a reaction, at a given desired flux, depends on thermodynamic and kinetic factors.
To see what each factor contributes, we split the formula for enzyme demands into a product of terms, each with a simple interpretation. The reaction rate depends on enzyme level, forward catalytic constant k + cat (i.e., the maximal possible forward rate per mM of enzyme), driving force (which determines the relative backward flux), and kinetic effects (such as substrate saturation or allosteric regulation) that modify the forward flux (see Figure 1 ). The catalytic rate of enzymes is decreased by different physical factors. Under ideal conditions, an enzyme molecule catalyses its reaction at a maximal rate, given by the enzyme's forward catalytic constant (top). The rate is reduced by microscopic reverse fluxes (center) and insufficient availability of substrate (incomplete saturation, leading to waiting times between conversion events). As the catalytic rate of the enzyme decreases (left), realizing a desired metabolic flux requires increasingly more enzyme (right).
Enzymatic rate laws
Reactions of the form A ⇌ B can be described by the reversible Michaelis-Menten kinetics. A generalized form for reactions with multiple substrates (concentrations s i ) and products (concentrations p j ) reads
D(s 1 , s 2 , .., p 1 , p 2 , ..) .
The molecularities m S i and m P i represent the (positive) stoichiometric coefficients, but they may be scaled by a reaction-specific factor which effectively acts like a Hill coefficient. Using a stoichiometric coefficient n il and a molecularity m S li = 2|n il | is equivalent to using a Hill coefficient of 2 in the rate law. For reasons of thermodynamic consistency, reaction rates must vanish in chemical equilibrium states; to ensure this, equilibrium constants and rate constants must satisfy the Haldane relationship [1]
where s i and p j denote to substrate and product levels, respectively. Since the equilibrium constants depend on the Gibbs energies of formation as K eq = e −∆rG 
In addition, the denominator may contain additive or multiplicative terms for allosteric activation and inhibition. The exponents m lik are usually positive integer numbers. With allosteric regulation, however, there can also be denominator terms of the form K S /s.
Separable rate laws and enzyme cost
Following [3] , we consider general reversible rate laws and factorize them into
where
cat is the forward catalytic constant. For an example of such a factorization, see appendix B. The energetic efficiency
depends on the mass-action ratio Γ (e.g., Γ = p/s for unimolecular reactions) and on the equilibrium constant K eq , or briefly on the driving force Θ = −∆ r G/RT . Note that our driving forces are defined via molecularities, not via the stoichiometric coefficients; to allow for a consistent equilibrium state, all reactants within a reaction must show the same Hill coefficient [4] . The relationship Γ/K eq = e −Θ links concentrations to driving forces and holds for ideal chemical mixtures with constant activity coefficients. The kinetic efficiency η kin depends on the rate law and can be derived from the rate law's denominator.
For a general reversible rate law, the kinetic efficiency would read
where the substrate-dependent
stems from the positive numerator term in the rate law and the denominator D is given by the rate law denominator. A factorized formula (4), called separable rate law [3] , exists for reactions of arbitrary stoichiometry (for examples, see SI A). The factorization is always possible even for general rate laws, because rate law numerators must have the form
The terms in the rate law (4) depend on metabolite levels in different ways. The first terms, ε·k 
By weighting the enzyme demand with an enzyme-specific cost h l , we obtain the cost function
Dividing Eq. (8) by v l , we obtain the specific flux cost Υ l = y l /v l = h l /r l . Eq. (8) shows which factors shape enzyme cost, and how. The first two terms yield the minimal cost Υ At the edges of the admissible region (where chemical equilibrium would obtain), the thermodynamic driving force goes to zero; this must be compensated by a high enzyme level. The enzyme demand in reaction 1 (shown in (b)), for instance, increases with the level of A (x-axis) and goes to infinity as the mass-action ratio a/x reaches the equilibrium constant (where the driving force vanishes). (e) Total enzyme demand (sum of enzyme levels). The metabolite polytope -the intersection of feasible regions for all reactions -is a triangle, and the enzyme demand is a cup-shaped function on this triangle. The minimum point marks the optimal metabolite levels, from which optimal enzyme levels can be computed.
the k cat values, driving forces (i.e. imbalance in substrate and product levels), and substrate saturation (i.e. high substrate concentrations) should be high. For a pathway with desired fluxes v l and known log-concentrations x i = ln c i , the total cost reads
Setting h l = 1, we obtain the total enzyme demand (as a concentration in mM), and setting h l = m l (protein mass in Daltons), we obtain the mass concentration (in gram protein per cell dry weight) as a special case.
The metabolite polytope represents the states of a kinetic model
A metabolic network (with given flux directions, equilibrium constants, and metabolite bounds) defines a convex metabolite polytope P in the space of log-concentrations x i = ln c i (where c i is measured in units of the standard concentration c σ = 1 mM). An example is shown in Figure 3 . In general, the polytope arises from two sorts of inequality constraints: (i) Upper and lower bounds x
for metabolite levels yield a box-shaped metabolite polytope; some metabolite levels may also be constrained to a fixed value. (ii) Reaction fluxes dissipate Gibbs energy (Θ l · v l > 0), so the driving forces must be positive in the direction of the flux. The resulting constraints 0 < Θ l = 1 RT ∆ r G ′ • l + i ln c i further restrict the metabolite polytope; they define E-faces of the polytope (representing an equilibrium condition), where enzyme costs rise steeply. The metabolite polytope is a convex polytope in log-concentration space, which contains all feasible metabolite profiles. It is bounded by two types of faces: faces that represent an equilibrium in one of the reactions ("E-face"), where enzyme cost goes to infinity; and faces stemming from physiological metabolite bounds ("P-face"). Minimum points of the enzyme cost function can be inside the polytope or on P-faces. The polytope's precise shape depends on the Enzyme Cost Function (ECF) score chosen (i.e, on the simplifications applied) and on rate laws, rate constants, and specific enzyme costs h l in the model.
The metabolite polytope plays a central role in enzyme cost minimization: For a given model and flux profile v, the points of the polytope parametrize the set of all possible steady states (ε, c, v). Feasible metabolite profiles (represented by polytope points) can be uniquely mapped to enzyme profiles, while the mapping from enzyme to metabolite profiles need not be unique. The entirety of metabolic states (or all steady states) of a kinetic model can be parametrized as follows: we consider the (non-convex) flux polytope and construct, for each point, the metabolite polytope. The construction yields all steady states (characterized by concentrations, fluxes, enzyme levels) exactly once (while the same enzyme profile may appear several times). Using this fact, we can parametrize all metabolites states of a kinetic model in a simple and systematic way (for details, see appendix C). However, a restriction to stable steady states is not easily possible.
Enzyme cost is a convex function on the metabolite polytope
The enzyme cost functions (8) and (9) are differentiable convex functions on the metabolite polytope (proof in SI D). Convexity means that an interpolated metabolite vector, on a line between two log-concentration vectors x a and x b , has a cost that is higher than (or at most equal to) the interpolated cost:
To show that the ECF scores are convex, we consider the most general rate laws with denominator (3) and rewrite it in the form
implying the enzyme cost function
for a pathway. The efficiency terms are given by
with coefficients α k ∈ R + and a ik ∈ R. The regulation efficiency η reg can be neglected because it can always be covered by the term η kin . The cost function (12) with efficiency terms (13) is convex on the metabolite polytope. The function stays convex if the investment function H(ε) is not linear, but convex. Importantly, even though all ECF scores are convex, they may not be strictly convex (in which case there would be a < sign, instead of ≤, in Eq. (10)). For instance, simplified ECF scores can be constant in the metabolite polytope. Non-strict convexity can arise when the mapping from enzyme to metabolite profiles is not unique. However, it is possible to enforce a unique optimum by adding a convex regularization term y reg , e.g., a quadratic function favoring metabolite levels in the center of the typical concentration range.
Such terms can be justified by biological side objectives: for instance, keeping metabolite levels away from their upper or lower bounds in advance will later allow cells to vary them more flexibly. We can also consider a variant of ECM with an additional metabolite-dependent objective z. Instead of minimizing the enzyme cost alone, we then minimize the difference y The convexity proof suggests that enzyme levels can be predicted with relatively little effort. Enzyme cost minimization uses a metabolic network, a given flux profile v, and possibly kinetic rate laws (with their thermodynamic or kinetic constants), and specific enzyme costs. The flux profile may be stationary (like flux profiles determined by FBA) or non-stationary (like experimentally measured fluxes, simply inserted into a model). In any case, it must be free of thermodynamically unfeasible cycles, and must agree with the assumed equilibrium constants and external metabolite levels. If the given flux directions are infeasible, the metabolite polytope will be an empty set. To find an optimal state, we choose an ECF score and minimize the total enzyme cost within the polytope. Optimal metabolite profiles, enzyme profiles, and enzyme costs are obtained by solving the Enzyme Cost Minimization (ECM) problem
for log-concentration vectors x = ln c. The total cost y pw (x) (see Eq. (9)) is a sum of enzyme costs (8) or simplified ECF scores. If there is no unique optimum for x (because the cost function is constant along some subspace, and therefore not structly convex), a unique solution can be enforced by adding a convex regularization term y reg (x) to y pw . Since the optimal enzyme levels depend on external metabolite levels, they must be recalculated after changes in external conditions. If non-enzymatic reactions (typically with ) ) and an investment h(ε 1 , ε 2 , ..). To predict an optimal enzyme profile, we maximize the difference z − h. (b) In ECM, a predefined flux profile is realized by an enzyme profile (and a corresponding metabolite profile) with a minimal investment; a concentration objective can be considered in addition. Using the metabolite concentrations as free variables makes the problem relatively easy to solve. mass-action rate laws) are included in the optimality problem, they contribute to the energetic constraints, but not to the enzyme cost function.
Discussion
In summary, we saw that logarithmic metabolite levels are suitable variables for screening, sampling, and optimizion of metabolic states. Due to the mapping from metabolite profiles to enzyme profiles, all feasible enzyme profiles can be reached, where bounds on driving forces can be formulated as linear constraints. Moreover, using the metabolite log-concentrations as free variables does not only provide a good search space, but also facilitates the optimization problem: under general and reasonable assumptions, the ECF scores are convex functions on the metabolite polytope. Convexity holds for a wide range of rate laws, including rate laws with allosteric regulation. As a consequence, the optimization remains tractable for various rate laws and larger metabolic networks. Strict convexity (required for an isolated optimum point) can be enforced by adding small regularization terms y reg , possibly representing biological side objectives.
Optimal enzyme allocation in kinetic models can be framed in two main ways. One the one hand, enzyme levels can be treated as control variables which determine the metabolic state, and thus the fluxes (see, e.g., [5, 6] ). The aim is to find the enzyme profile that leads to an optimal state (where enzyme cost can come into play as a constraint or as a penalty functions). On the other hand (as in [7, 8] and here), one can predefine the fluxes and search for enzyme levels that realize them in an optimal way (here, minimal cost is used as the optimality criterion). Both approaches address similar problems and lead to equivalent solutions. For instance, if we first maximize a flux at a fixed total enzyme level, as in [6] , and then use this flux as a constraint in ECM (with identical specific costs for all enzymes), we recover the metabolite and enzyme profile from the initial calculation. In fact, both optimality problems can be derived from a common general optimality problem by constraining the fluxes or the total enzyme cost. The approaches frame the same problem, but in different ways. Using fluxes as a scaffold for model construction has several advantages. First, it makes the optimality problem convex. Second, we can precisely specify the flux state to be modelled. Third, the flux cost functions y opt (v) can be used in flux analysis. Thus, ECM enables more realistic variants of FBA; the cost function may contain additional side objectives scoring the metabolite levels. If flux profiles are compared at a given flux benefit, it is only the cost scores that count in the optimization, so cost and benefit can be measured in different units. In benefit-cost approaches as in Figure 4 (a), enzyme investment and metabolic objective are directly compared and show the same physical units. In order to make them comparable, a relative weighting would have to be established, which bears the problem of arbitrariness.
Our fundamental assumption -that enzyme levels are cost-optimized in every moment -is of course debatable. Instead, proteins may be expressed to higher amounts to anticipate sudden challenges (example: energy production in muscle cells). Preemptive protein expression can avoid costs for rearranging the proteome and performance losses during adaptation; however, in ECM it would appear futile. Also flexibility in metabolite concentrations can be important, and cells might trade it against enzyme economy. Furthermore, enzyme and metabolite levels in cells are not only shaped by demands in a single pathway, but also by other pathways outside the model in question. Finally, if proteins are used as an amino acid storage, there will be little pressure to keep them at low concentrations. How can our method be useful despite all this? First, an account of simple enzyme economy can be a basis for studying more complicated optimality requirements afterwards. Second, despite all these points of critique, enzyme economy may be the main requirement, e.g., during fast, nitrogen-limited growth. Third, we can study how deviations from the optimal state affect enzyme cost, and thus fitness. Finally, ECM can be extended to include more objectives and constraints into our pathway model, and thus to account for the surrounding cell. The metabolites from our pathway may also be involved in other pathways outside the model. If these other pathways demand higher or lower metabolite levels, we can implement this fact in ECM by constraints (upper and lower concentration bounds) or by concentration-dependent side objectives z met (c), which penalize unfavorable metabolite levels. Trade-offs between the pathway in focus and other pathways around it can be handled in this way. Alternatively, we can assume that each metabolite level should be close to the centre of its allowed range (which also provides flexibility, because it will not easily hit a bound).
Again, this can be captured by side objectives.
As a possible application, enzyme cost functions allow us to define non-linear flux costs for use in flux balance analysis. ECM is based on a given flux profile. However, since it can be applied to any flux profile, it defines a flux cost function y opt (v), which can be applied in flux prediction. other enzyme optimality approaches [9, 10] . In fact, the flux cost function y opt (v) can be expected to be strictly concave (except for specific cases, e.g. models containing two identical reactions with identical rate laws). If this is this case, elementary flux modes are the only solutions. As a consequence, splitting a flux profile into elementary modes that run in different compartments or at different time points can be better, but never worse than the original flux profile in terms of enzyme cost. 
A Kinetic rate laws
By considering simple enzyme mechanisms with few binding states, we obtain general rate laws applicable to all reaction stoichiometries. The rate law denominators to be used in Eq. (1) have simple structures
(containing only few of the possible sum terms, and with prefactors following from a few Michaelis-Menten constants) [4] . If denominator terms are omitted, the rate will be overestimated, i.e., enzyme demand and costs will be underestimated. First, there are rate laws with denominators
which lead to the energetics-based ECF2 scores. The big product terms are called principal substrate and product terms. As before, s i and p j denote substrate and product levels. The first formula assumes that substrate levels are high and product levels are low; the second one assumes that substrate and product levels are both high. Next, there are rate laws with denominators
which lead to the saturation-based ECF3 scores. The denominators contain only three possible terms: the term 1, the principal substrate term, and the principal product term. To justify these rate laws, we assume a strongly cooperative binding between substrates and between products. The first formula assumes low product concentrations; the second formula describes the direct-binding modular rate law [4] . The directbinding modular rate law is a generalized version of reversible MM kinetics. In the underlying enzyme mechanism, the enzyme exists in three states: fully bound with substrates, fully bound with products, or empty. If enzymes are allosterically regulated, the rate law denominators contain additive or multiplicative terms for regulation [4] . Additive terms can arise from competitive regulation. Multiplicative terms (for non-competitive regulation) can be split from the denominator and treated as prefactors in the rate law. Typical choices are For instance, the kinetic efficiency term for MM-kinetics with non-competitive inhibition can be split into
B Factorization of rate laws
To demonstrate how rate law are factorized, we consider the common modular rate (CM) law [11, 4] , a generalized form of reversible MM kinetics with the denominator
In the assumed enzyme mechanism, substrate molecules bind independently, product molecules bind independently, and substrate and product binding exclude each other. For a bimolecular reaction A + B ⇋ P + Q, the rate law
KA KB − k
KB ) + (1 +
[P ]
can be rewritten as
KA KB − 
C Parametrizing all states of a kinetic model
In a kinetic model with given rate laws and external metabolite concentrations, an enzyme profile (ε 1 , ..ε 2 , ..)
lead to a steady state with metabolite levels c and fluxes v. The following proposition shows how the set S of such steady states σ = (ε, c v) can be easily parametrized.
Proposition: Consider a kinetic model with rate laws v l = ε l r l (c), thermodynamically consistent rate constants (satisfying Wegscheider conditions and Haldane relationships), a feasible positive flux profile v, and bounds on metabolite levels. Any feasible metabolite profile ln c ∈ P can be realized by some positive enzyme profile ε; given the metabolite levels, the enzyme levels are uniquely determined and given by ε l (ln c) = v l /r l (c), which is a differentiable function on the metabolite polytope.
Proof: If a metabolite profile c is feasible for the given flux profile v, the specific rates r l (c) obtained from reveresible rate laws (see Eq.
(1) in appendix) have the same signs as v l , so ε l = v l /r l (c) is positive on the entire metabolite polytope. Since r l (c) is differentiable and does not change its sign on the metabolite polytope, ε l (ln c) is differentiable on the metabolite polytope.
According to our proposition, any thermodynamically feasible metabolite profile can be realized by some steady state of the kinetic model (with an appropriate choice of enzyme levels), so the set S of metabolic states with a given flux profile v can be characterized by points of the metabolite polytope. In particular, the set of kinetically realizable metabolite profiles depends on the equilibrium constants, but not on enzymespecific rate constants. Finally, to parametrize all steady states of a kinetic model, we can follow a two-step procedure in which we enumerate all possible flux distributions and, for each of them, all possible enzyme and metabolite profiles. The thermodynamically feasible flux distributions v form a set V, given by V = {v|∃x :
, where x stands for log-concentration profiles. The reaction Gibbs ener-
l + RT i n il ln c i depend on the internal and external metabolite levels and on the equilibrium constants chosen. According to thermodynamic condition, whether a flux distributions is feasible or infeasible depends solely on its sign pattern. By imposing upper and lower bounds and the stationarity condition, we can further limit this set and obtain the set of feasible, stationary fluxes 
D Convexity proof for enzyme cost functions
To prove the convexity of general enzyme cost functions, on the metabolite polytope and at given desired fluxes, we first show the convexity of some simple functions appearing in the formula.
D.1 General lemmata Lemma 1
The function f (y) = − ln(1 − e y ) is convex in the range y < 0. is positive semi-definite, which proves that f (x) is convex.
Lemma 3 For any number ν ∈ R + and vector n ∈ R m , the function − ln(1 − ν e n·x ) is convex over {x ∈ R m | ν e n·x < 1}.
Proof D.3
This function is a composition of f = − ln(1−e y ) from Lemma 1 with the affine transformation y = n · x + ln ν, an operation which preserves convexity. 
Lemma 4 For any matrix

D.2 The convexity of enzyme cost functions
Lemma 5 Assume that all enzyme-catalysed reactions in a model behave according to rate laws of the type
with η th and η kin given by Eq. (13), with coefficients α k ∈ R + and a ik ∈ R. Assume that the enzyme cost function for enzymatic reaction l reads
Then the total enzyme cost y = l y l , as a function of logarithmic metabolite concentrations (x = ln c), is convex. 
we see that each of the three terms in the sum is convex in x. The first term is constant with respect to the metabolite concentrations and therefore trivially convex. The energetic term, − ln η th = − ln(1 − ν e −n·x ), is convex according to Lemma 3. The kinetic term, − ln η kin = ln n k=1 e a k ·x+b k , is convex according to Lemma 4. We conclude that y l is convex too, since it is a composition of a convex function (e x ) with another convex function (ln y l ). Finally, the total enzyme cost (y) is convex since it is a sum of convex functions:
